Comparison of efficacy of botulin toxin in women with de novo overactive bladder and idiopathic overactive bladder

Trial Profile

Comparison of efficacy of botulin toxin in women with de novo overactive bladder and idiopathic overactive bladder

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Feb 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Feb 2017 New trial record
    • 01 Mar 2016 Primary endpoint of complete dryness measured at 12 weeks has not been met, according to results published in the International Urogynecology Journal.
    • 01 Jun 2014 Recruitment competed according to according to results published in the International Urogynecology Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top